Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Thin film drug delivery Stories

2013-06-25 23:27:36

Essential Source®, a market leader in specialty nutraceutical products, combats insomnia and RMS (Restless Mind Syndrome) naturally, utilizing new dissolvable strip technology for rapid absorption. Phoenix, AZ (PRWEB) June 25, 2013 According to the Centers for Disease Control (CDC), an estimated 50-70 million U.S. adults have sleep or wakefulness disorder, such as insomnia. Persons experiencing sleep insufficiency are also more likely to suffer from chronic diseases such as...

2013-04-22 08:28:56

MIAMI, April 22, 2013 /PRNewswire-USNewswire/ -- Fuisz Pharma today announced its intent to divest its strategic issued patent for the detection of opioid abuse (US 7,214,385 "Pharmaceutical Formulation Containing Dye"). This patent covers the use of dyes and staining agents in pharmaceutical dosage forms as a method to prevent the improper use of opioid drugs by visually demonstrating their misuse and abuse. For example, where a patient abuses a drug like oxycodone through nasal snorting,...

2012-10-02 02:30:05

MIAMI, Oct. 2, 2012 /PRNewswire/ -- Fuisz Pharma announced today a patented film formulation for enhanced drug delivery performance. The seminal patent for this technology issued as United States Patent 8,241,661 ("Biocompatible Film with Variable Cross-Sectional Properties"). Joseph Fuisz Esq., managing member for Fuisz Pharma, explained: "It is understood that bi-layer film compositions can offer improved buccal absorption characteristics by retarding the drug that is lost to salivary...

2012-06-19 02:27:53

MIAMI, June 19, 2012 /PRNewswire/ -- Femina Pharma Incorporated announced the issuance of US Patent 8,178,123. This patent covers methods of improving drug delivery, particularly for cancer and HIV/AIDS populations. Prof. Giovanni Pauletti, a named inventor of the patent, explains the background and significance of the '123: "The gastrointestinal tract is physiologically designed to digest food, absorb nutrients, and serve as an effective barrier protecting the internal milieu of the body...

2012-06-06 06:26:41

BETHLEHEM, Pa., June 6, 2012 /PRNewswire/ -- Particle Sciences, a leading drug delivery CRO, has added new coating capabilities for preparing polymer film-based drug products from liquid formulations, under cGMPs. According to Garry Gwozdz, Director, Formulation Services, "Particle Sciences' purpose is to provide our clients with the most efficient drug product. Increasingly, we are seeing a demand for thin film-based products, particularly with respect to transdermal drug-eluting patch...

2011-08-17 07:00:00

MIAMI, Aug. 17, 2011 /PRNewswire/ -- Fuisz Pharma (www.fuisz.com) today announced the publication of U.S. Patent Application US 20110182827 ("Method and Dosage Form to Confirm Compliant Use of a Bioactive Agent"). This patent pending is directed towards a dosage form that includes a substance that is visible to a normal light or to a special light source in the buccal or vaginal cavity in order for medical personnel to confirm compliant use of a medication. The substance leaves behind a...

2011-04-06 07:00:00

MIAMI, April 6, 2011 /PRNewswire/ -- Fuisz Pharma LLC announced today a new generation of solid dosage form designs that facilitate swallowing and esophageal transit. Clinical studies demonstrate that these new designs and principles thereof speed esophageal transit by 80%, ease the swallowing experience, and reduce the incidence of esophageal transit failure, as compared with the conventional tablet designs currently used. Joseph Fuisz, managing partner of Fuisz Pharma stated: "We stand...

2011-02-07 07:00:00

MIAMI, Feb. 7, 2011 /PRNewswire/ -- Based on U.S. Patent 7,824,612 ("Body Fluid Analyzer and System including Same and Method for Programming Same"), Fuisz Pharma today announced the use of their patented Technology to create a new class of microchip containing smart tablets that communicate with personal body fluid analyzers. These tablets wirelessly inform a body fluid analyzer of acceptable analyte values for body fluids, set by the drug company so that the analyzer can provide alerts...

2010-12-14 06:03:00

WARREN, N.J. and PORTAGE, Ind., Dec. 14, 2010 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, announced today it secured favorable terms to refinance the company's debt with White Oak Global Advisors, LLC. Under this agreement MonoSol Rx is refinancing $20 million. Specific terms were not disclosed. MonoSol Rx will use the funds for general corporate purposes,...

2010-09-21 07:00:00

MIAMI, Sept. 21 /PRNewswire-USNewswire/ -- Fuisz Pharma (www.fuisz.com) today announced several advances in pharmaceutical compliance diagnostic systems, primarily directed at Opioids but also applicable to other drug classes. First, Fuisz placed its recent acquisition of the dominant, issued patent concerning the use of dyes and stains to demonstrate opioid misuse, within the larger context of Fuisz's compliance system. Fuisz calls this system Closed Loop Diagnostic System (CLDS)....